TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
A safer and more effective anticancer drug has been discovered by researchers from the University of Florida College of Pharmacy. The new treatment would target leukemia, lymphoma, and breast and lung cancers....
A new treatment and an industrial fabrication process called coaxial electrospinning have been developed by the researchers at the University of Cincinnati for the treatment of glioblastoma multiforme or GBM....
The researchers at the University of California, Riverside in collaboration with researchers at City of Hope National Medical Center have invented deterministic mechanoporation or DMP - a novel microfluidic device technology to treat cancer....
The researchers at the University of Liverpool have made a new discovery in the field of cell signaling. Generally, the signaling in cell regulates cell growth and repair in humans. However, abnormal cell signaling can lead to many diseases, including cancer and neurodegeneration....
The researchers from the University of California have discovered the structure of ZCCHC4, a novel RNA-modifying enzyme. The cell proliferation is influenced by ZCCHC4 and has been linked to cancers. Apart from this, they also identified the mechanism that controls how the ZCCHC4 enzyme recognises its substrate....
A simple saliva test has been developed by the researchers at the University of Bath to detect if someone has recently taken the street drug ‘spice’. The substance known as ‘spice’, is usually a mixture of dried and shredded plant material, sprayed with various synthetic chemicals meant to mimic the main component of cannabis....
Mirum Pharmaceuticals has launched a novel drug Maralixibat, for the treatment of pruritus associated with Alagille syndrome (ALGS) in patients one year of age and older. ALGS is a rare genetic disorder within which digestive juice ducts are abnormally slim, unshapely and reduced in a range that ends up in digestive juice within the liver and ultimately progressive disease....
A new oral medication, REYVOW™ (lasmiditan) has been launched by Eli Lilly and Company for the treatment of acute migraine, with or without aura, in adults. The drug, REYVOW is delivered orally via a tablet and is the first serotonin receptor agonist. It binds to (5-HT) 1F receptor with high affinity....
A new oral inhibitor, cobimetinib (Cotellic) has been launched by the Memorial Sloan Kettering Cancer Center (MSK) for the treatment of adult patients with histolytic neoplasms (HN) (Erdheim-Chester Disease, Rosai-Dorfman, Langerhans Histiocytosis)....
A new orally-administered poly ADP-ribose polymerase (PARP) inhibitor, Niraparib has been launched by the Janssen Pharmaceutical Companies of Johnson & Johnson....
A new ultrasensitive nanoscale optical probe has been developed by the researchers at UC Santa Cruz that can monitor the bioelectric activity of neurons and other excitable cells....
A new medication, Ofev® (nintedanib) has been launched by Boehringer Ingelheim for the treatment of patients with chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype....
Genentech, a member of the Roche Group announced that a new lymphoma medicine under the name Gazyva® (obinutuzumab) has been launched to treat adults with lupus nephritis....
SpringWorks Therapeutics has launched its experimental drug, nirogacestat for the treatment of adult patients with rare and progressive cancer known as desmoid tumors....
An investigational prophylactic vaccine has been launched by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease....
Pegzilarginase, an investigational therapy has been launched by Aeglea BioTherapeutics for the treatment of Arginase 1 Deficiency (ARG1-D). Pegzilarginase is an enhanced human arginase that is intended for use as an enzyme replacement therapy in patients to reduce the elevated blood arginine levels....
The University of North Carolina (UNC) Lineberger Comprehensive Cancer Center researchers have discovered a hyperactive cell that contributes to tumor growth in primary effusion lymphoma and a potential treatment strategy to block down its downstream effects....
Dicerna Pharmaceuticals announced that its investigational drug, DCR-PHXC is used for the treatment of patients with primary hyperoxaluria type 1 (PH1), a rare genetic liver disorder that often results in kidney failure....
US-based biotechnology company, PanTheryx, in partnership with Zuellig Pharma, a healthcare company in Asia, announced the launch of innovation of DiaResQ for diarrhea relief in Cambodia....
University of Otago researchers have discovered a novel property of a new anti-tuberculosis drug which may help develop more drugs to treat the top infectious killer disease in the world. Bedaquiline is the first new drug to be developed after 40 years for more effective combat against TB....
West Virginia University researchers mapped the crystal structure of the protein and located how a drug fixes on it. Researchers revealed how medications are attached to the proteins in our body, how they work and what form they acquire....
Syqe Medical launched the world's first pharmaceutical-grade metered-dose cannabis inhaler in Israel. The eight years of research and development including rigorous testing through multiple clinical trials paved a novel regulatory path....
Researchers and scientists at the University of Illinois at Chicago and AbbVie Inc. developed a novel device to screen and test formation of drug substance-Active Pharmaceutical Ingredient (API)....
Bayer launched a breakthrough therapy AliqopaTM (Copanlisib) for the treatment of Marginal Zone Lymphoma (MZL). Aliqopa (Copanlisib) is an intravenous phosphatidylinositol-3-Kinase (PL3K) inhibitory activity predominantly...
Harvard University chemist's synthesis of halichondrin is known to be a potent anti-cancer agent. Harvard University Chemists have achieved a landmark in drug discovery spending three decades in making it....
